Navigation path

Countries
Countries
  Argentina
  Australia
  Austria
  Belgium
  Benin
  Brazil
  Bulgaria
  Canada
  Chile
  China
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport


   Success Stories

Last Update: 20-06-2012  
Related category(ies):
Health & life sciences  |  Special Collections  |  Research policy

 

Countries involved in the project described in the article:
Israel
Add to PDF "basket"

NA-NOSE – The simple breath test that can detect cancer

No-one wants to be told that they have cancer. But the earliest possible diagnosis is often the key to ensuring survival. So a new technique developed by scientists wich can instantly detect cancer even in its very earliest stages, using just a simple breath-test, offers the clear hope of a major breakthrough in improving cancer survival rates.

Designed to mimic a dog's highly sensitive sense of smell, the new "electronic nose" takes a sample of the patient's breath and gives an instant reading - not only of whether cancer is present, but how far advanced it is. Early tests for the device have already shown extremely exciting results.

Known as the NA-NOSE (short for Nano Artificial Nose), the test works by spotting microscopic changes in the body that occur when cancer is present.

By detecting cancer without having to wait for tumours to grow, the NA-NOSE offers a unique early warning system that could save thousands of lives, allowing cancers to be diagnosed and treated earlier than has ever been possible before. It would be especially valuable in diagnosing cancers that are otherwise hard to detect in time.

Nor does it stop with cancer. The NA-NOSE will potentially be able to pick up early signs of other serious diseases as well, such as Parkinson's, Kidney Disease, Liver Disease, Alzheimer's or MS – making it truly a "'wonder device".

"At first, I thought to myself this is science fiction. It can't be true", says Professor Abraham Kuten, one of the scientists involved in developing the NA-NOSE. But based on the successful results so far, Professor Kuten says, it could turn out to be "a very important tool in the early detection of cancer."

The potentially breakthrough project was funded by a € 1.7 million Marie Curie Excellence Team grant from the European Commission. These grants are designed to enable promising researchers to carry out leading-edge research of particular importance to Europe.

In the case of the NA-NOSE, that grant could be repaid many times over in saved health care costs, if early test results are anything to go by.

When breath-tests were carried out on an initial group of 62 volunteers - some with head and neck cancer, some with lung cancer, and some of whom were healthy - the NA-NOSE correctly diagnosed all of the patients with the two types of cancer. It also correctly identified all but two of the healthy patients of the healthy patients.

The secret of the NA-NOSE lies in a row of sub-microscopic (nanoparticle) gold sensors, which can detect tiny molecular changes that occur in the blood of cancer patients. They can do this at levels of concentration so low that it has been likened to detecting one single flower in a vast field of flowers - using the sense of smell alone.

Using these tiny molecular traces, the device can not only detect cancer but also distinguish between different types of cancer including lung, breast, colorectal, prostate, head and neck.

The scientist who led the research, Professor Hossam Haick of the Israel Institute of Technology (Technion), was inspired to carry out the research after witnessing the sufferings of a friend who had leukaemia.

Extensive further testing of the NA-NOSE will be required. But if all goes well, says Professor Haick, it could be in use for breast and colorectal cancer patients within three years and for other types of cancer in about seven years.

Thanks to this revolutionary new "electronic nose", with its promise of reliable, noninvasive and inexpensive early diagnosis, screening for cancer could be on the verge of entering a whole new world.

The ability to literally "sniff out" cancer and other major diseases could indeed become a reality.

Project details

  • Participants: Israel (Coordinator)
  • FP6 Project N° 42348
  • Total costs: € 1 730 000
  • EU contribution: € 1 730 000
  • Duration: April 2007 - March 2011

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Project web site

Project information on CORDIS

Contacts
Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center